Pe
Peking Univ Cancer Hosp
NPBeijing CNFounded 19763,000 employees
Private CapacadPrivateOncology
Platform: Cancer Center
Market Cap
N/A
All Drugs
6
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (6 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PEK-IIT-569 | PEK-IIT-569 | Preclinical | 1 | PARP | PAH | ||
| PEK-IIT-463 | PEK-IIT-463 | Preclinical | 1 | WEE1 | ADPKD | ||
| PEK-IIT-810 | PEK-IIT-810 | Phase 1/2 | 1 | BCMA | NASH | ||
| PEK-IIT-794 | PEK-IIT-794 | Phase 1/2 | 1 | GLP-1R | Obesity | ||
| PEK-IIT-150 | PEK-IIT-150 | Phase 1 | 1 | MALT1 | CML | ||
| PEK-IIT-646 | PEK-IIT-646 | Phase 1 | 1 | APOC3 | Wet AMD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)